Can cinnamon and education ease diabetic nerve pain?
NCT ID NCT07496619
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at whether a diabetes education program plus cinnamon supplements could help adults with type 2 diabetes who have painful nerve damage in their feet. Sixty-two participants were split into two groups and followed for six months. Researchers measured changes in blood sugar, cholesterol, body weight, and pain levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cinnamon supplement
- What this could lead to
- If it works, this could point toward a simple, low-cost way to help manage blood sugar and nerve pain in people with type 2 diabetes.
- What could go wrong
- This was a small, short-term study (62 people, 6 months) without a placebo, so results may not be reliable or apply to everyone. Cinnamon supplements can also interact with other medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
62 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Aug 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * adult patients (aged 18 years or older) * diagnosed with painful diabetic peripheral neuropathy at Ministry of Health Clinics in 2021. Exclusion Criteria: * Participants with chronic conditions such as chronic kidney disease (CKD). * Hypertension patients. * Cardiovascular disease (CVD). * Other coexisting medical issues, including cognitive impairment or sensory impairments (e.g., reading or hearing difficulties). * Individuals who had received treatments that could influence blood glucose levels or pain perception during basic insulin and peripheral neuropathy (PNP) therapy (such as glucocorticoids, weight-loss medications, or therapies related to vitamin B12 or iron supplementation).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cholesterol (total and HDL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al-Quds University
East Jerusalem, Abu Dies, Palestinian Territories
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a finger sensor reveal whether an epidural is working?
- Heartbeat test aims to catch hidden nerve damage in diabetes
- Can Home-Delivered meals help control diabetes?
- New pill takes aim at stubborn blood sugar
- Five simple signs could help nurses score surgical pain in turkish
- Gene therapy shots aim to save legs from amputation in diabetes